Substance Use Disorders and Telehealth in the COVID-19 Pandemic Era
| Autor: | Melanie T. Gentry, Mark S. Gold, Daniela B. Rakocevic, Cameron J. Risma, Mohit Chauhan, Larissa L. Loukianova, Teresa A. Rummans, Daniel K. Hall-Flavin, B Kolla, Tyler S. Oesterle, Scott Breitinger |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2020 |
| Předmět: |
medicine.medical_specialty
education.field_of_study business.industry Social distance medicine.medical_treatment Population Psychological intervention Opioid use disorder Telehealth General Medicine 030204 cardiovascular system & hematology medicine.disease Discontinuation Substance abuse Group psychotherapy 03 medical and health sciences 0302 clinical medicine Medicine 030212 general & internal medicine business Intensive care medicine education |
| Zdroj: | Mayo Clinic Proceedings |
| ISSN: | 0025-6196 |
| DOI: | 10.1016/j.mayocp.2020.10.011 |
| Popis: | During the current coronavirus disease 2019 epidemic, many outpatient chemical dependency treatment programs and clinics are decreasing their number of in-person patient contacts. This has widened an already large gap between patients with substance use disorders (SUDs) who need treatment and those who have actually received treatment. For a disorder where group therapy has been the mainstay treatment option for decades, social distancing, shelter in place, and treatment discontinuation have created an urgent need for alternative approaches to addiction treatment. In an attempt to continue some care for patients in need, many medical institutions have transitioned to a virtual environment to promote safe social distancing. Although there is ample evidence to support telemedical interventions, these can be difficult to implement, especially in the SUD population. This article reviews current literature for the use of telehealth interventions in the treatment of SUDs and offers recommendations on safe and effective implementation strategies based on the current literature. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|